Chemotherapy for Myelodysplastic Syndrome (MDS)
Chemotherapy Drugs Used for MDS
- Cytarabine and idarubicin
- Cytarabine and topotecan
- Cytarabine and fludarabine
- Decitabine (Dacogen)
- Azacitidine (Vidaza)
- Lenalidomide (Revlimid)
- Anti-thymocyte globulin (ATG)
Effectiveness of Chemotherapy
Side Effects and Possible Complications
Castro-Malaspina H, O’Reilly RJ. Aplastic anemia and the myelodysplastic syndromes. In Harrison's Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998.
Chiodi S, Spinelli S, et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol. 2000;110:614
Detailed guide: myelodysplastic syndromes. American Cancer Society website. Available at: http://www.cancer.org/docroot/CRI/CRI%5F2%5F3x.asp?dt=65. Accessed April 2, 2009.
Detailed guide: myelodysplastic syndromes—chemotherapy. American Cancer Society website. Available at: http://www.cancer.org/Cancer/MyelodysplasticSyndrome/DetailedGuide/myelodysplastic-syndromes-treating-chemotherapy. Updated January 12, 2012. Accessed February 27, 2012.
Drug Facts and Comparisons. 56th ed. St. Louis, MO: Facts & Comparisons; 2001.
Léger CS, Nevill TJ. Hematopoietic stem cell transplantation: a primer for the primary care physician. CMAJ. 2004;170:1569.
- Reviewer: Mohei Abouzied, MD, FACP
- Review Date: 12/2014 -
- Update Date: 12/20/2014 -